Search details
1.
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.
Mult Scler
; 29(9): 1070-1079, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37317870
2.
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta-analysis.
Alzheimers Dement
; 19(4): 1292-1299, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36043526
3.
A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis.
Mult Scler
; 27(14): 2240-2253, 2021 12.
Article
in English
| MEDLINE | ID: mdl-33821693
4.
Neurofilaments: neurobiological foundations for biomarker applications.
Brain
; 143(7): 1975-1998, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-32408345
5.
Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letter.
Alzheimers Dement
; 2022 Nov 16.
Article
in English
| MEDLINE | ID: mdl-36383475
6.
Slowly expanding lesions are a marker of progressive MS - No.
Mult Scler
; 27(11): 1681-1683, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34474615
7.
Assessing the utility of magnetic resonance imaging-based "SuStaIn" disease subtyping for precision medicine in relapsing-remitting and secondary progressive multiple sclerosis.
Mult Scler Relat Disord
; 77: 104869, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37459715
8.
Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials.
Sci Rep
; 13(1): 14313, 2023 08 31.
Article
in English
| MEDLINE | ID: mdl-37652990
9.
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study.
CNS Drugs
; 35(9): 1009-1022, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34322853
10.
Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarate.
Neurol Neuroimmunol Neuroinflamm
; 6(3): e562, 2019 05.
Article
in English
| MEDLINE | ID: mdl-31086805
11.
Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS.
Neurol Neuroimmunol Neuroinflamm
; 5(4): e470, 2018 Jul.
Article
in English
| MEDLINE | ID: mdl-30283812
12.
Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis.
Front Neurol
; 9: 561, 2018.
Article
in English
| MEDLINE | ID: mdl-30057565
13.
Towards the incorporation of lumbar puncture into clinical trials for multiple sclerosis.
Mult Scler
; 18(10): 1509-11, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22298590
14.
Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation.
JAMA Netw Open
; 5(2): e2147588, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-35133438
15.
Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis.
PLoS One
; 12(1): e0169546, 2017.
Article
in English
| MEDLINE | ID: mdl-28081190
16.
CCSVI-A. A call to clinicans and scientists to vocalise in an Internet age.
Mult Scler Relat Disord
; 3(2): 143-6, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-25878001
17.
Observations and hypothesis on an individual patient topically treated for capecitabine-induced Palmar-Plantar syndrome.
BMJ Case Rep
; 20102010 Nov 09.
Article
in English
| MEDLINE | ID: mdl-22789554
Results
1 -
17
de 17
1
Next >
>>